Sanofi (SNW2) — Cash Flow Quality Index
Sanofi (SNW2) has a Cash Flow Quality Index of 1.34x as of September 2025. Operating cash flow of €3.75 Billion exceeds net income of €2.80 Billion, indicating high earnings quality where cash backs reported profits. Explore SNW2 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sanofi Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Sanofi across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Sanofi (SNW2) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Sanofi (2016–2024)
Year-by-year earnings quality comparison for Sanofi. For live market cap and the full company financial profile, see SNW2 company net worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.63x | €9.08 Billion | €5.56 Billion | ▼ -14.0% |
| 2023 | 1.90x | €10.26 Billion | €5.40 Billion | ▲ +21.3% |
| 2022 | 1.57x | €10.53 Billion | €6.72 Billion | ▼ -7.4% |
| 2021 | 1.69x | €10.52 Billion | €6.22 Billion | ▲ +180.7% |
| 2020 | 0.60x | €7.42 Billion | €12.31 Billion | ▼ -78.1% |
| 2019 | 2.75x | €7.71 Billion | €2.81 Billion | ▲ +113.4% |
| 2018 | 1.29x | €5.55 Billion | €4.31 Billion | ▲ +46.9% |
| 2017 | 0.88x | €7.38 Billion | €8.42 Billion | ▼ -47.3% |
| 2016 | 1.66x | €7.84 Billion | €4.71 Billion | — |